ADPT- Adaptive Biotechnologies Corporation

Name: Adaptive Biotechnologies Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robins Chad M	2.18M	$53.83M	-
Other	Bobulsky Susan	401.3K	$9.91M	-5,000
CFO	Piskel Kyle	256.7K	$6.34M	-
Other	Lo Francis	230.7K	$5.70M	-105,762
Other	Benzeno Sharon	113.5K	$2.80M	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2022	Rubinstein Julie78	President	Sell	4,613	$12.01	$55,402.13	-2.0%	-41.9%	-26.5%
Mar 7, 2022	Benzeno Sharon78	Chief Business Development Off	Sell	2,670	$12.01	$32,066.70	-2.5%	-41.9%	-26.5%
Mar 7, 2022	Taylor Stacy L82	SVP And General Counsel	Sell	1,569	$12.01	$18,843.69	-2.0%	-41.9%	-26.5%
Mar 7, 2022	Piskel Kyle	Principal Accounting Officer	Sell	220	$12.01	$2,642.20	-0.5%	-41.9%	-26.5%
Mar 7, 2022	Lo Francis78	Chief People Officer	Sell	1,569	$12.01	$18,843.69	-1.7%	-41.9%	-26.5%
Mar 7, 2022	Robins Harlan S83	Chief Scientific Officer	Sell	4,517	$12.01	$54,249.17	-1.4%	-41.9%	-26.5%
Mar 7, 2022	Robins Chad M62	CEO And Chairman	Sell	4,424	$12.01	$53,132.24	-0.2%	-41.9%	-26.5%
Mar 7, 2022	Adams R Mark88	Chief Operating Officer	Sell	1,244	$12.01	$14,940.44	-1.0%	-41.9%	-26.5%
Jan 7, 2022	Adams R Mark88	Chief Operating Officer	Sell	1,021	$23.32	$23,809.72	-2.0%	-43.1%	-64.0%
Dec 22, 2021	Taylor Stacy L82	SVP And General Counsel	Sale+OE	15,338	$30.00	$460,140.00	-50.5%	-54.6%	-72.5%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC